The embolization agents market in South and Central America is expected to grow from US$ 167.17 million in 2021 to US$ 262.40 million by 2028; it is estimated to grow at a CAGR of 6.7% from 2021 to 2028.
Embolization agents are used to acutely stop the flow in a blood vessel or vascular territory by the means of mechanical occlusion. Embolization is a common procedure in interventional radiology. Embolizing agents like embolic microspheres (beads) are used to restrict the vascular supply of tumors and can be loaded with chemotherapeutic medicines, which elute and diffuse into the tissue. Liquid embolic agents are used to prevent blood supply to aneurysm or tumor. It helps in the prevention of aneurysms and tumors from growing and causing harm to essential organ. Thus, increasing prevalence of aneurysms and cancers is creating high demand for South and Central America embolization agents marketThe increasing number of COVID-19 cases in Brazil, Peru, Chile, Ecuador, and Venezuela is likely to have negative impact on the South and Central America embolization agents market. For instance, in Brazil, the number of cases has reached ~18,513,305, with 516,119 deaths, as per the world meter data of June 2021. With the onset of the second wave of COVID-19 pandemic, there has been an increasing number of cases in the South American countries. According to the International Council of Nurses, the number of deaths of health professionals in Brazil are greater than the numbers in other countries, which can be associated with the high transmission of the virus. As Brazil has many populated regions with small houses with 6-7 people per house, the virus has spread rapidly. Currently, the countries in this region are rapidly increasing its clinical programs to fight against the novel coronavirus. In this scenario, Brazil is facing enormous difficulties in the management of cancer, head and neck surgeries, chronic neurological disorders such as brain aneurysms, and headache and neurodegenerative diseases. Due to inadequate monitoring, many patients end up being admitted to emergency departments due to decompensation of their cancer and neurological disease. During the pandemic, patients with cancer and stroke, as well as other neurological conditions, have been arriving late at the hospital, and the treatment procedures of such patients fall outside the therapeutic window for acute intervention. In addition, the country also faced difficulties in obtaining beds in the intensive care unit for management of these disease amid the COVID-19 crisis. These factors are limiting the South and Central America embolization agents market growth.
South and Central America Embolization Agents Market Revenue and Forecast to 2028 (US$ Million)

- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
South and Central America Embolization Agents Market Segmentation
South and Central America Embolization Agents Market – By Product
- Coils
- Detachable Coils
- Pushable Coils
- Beads/ Particles
- Spherical
- Non-Spherical
- Plugs
- Detachable Balloons
- Glue
- Sponge
- Liquid Embolics
- Sclerosants
- Precipitating Agents
- Others
- Detachable Coils
- Pushable Coils
- Spherical
- Non-Spherical
South and Central America Embolization Agents Market – By Application
- Oncology
- Neurology
- Urology
- Cardiology
- Peripheral Vascular Diseases
- Others
South and Central America Embolization Agents Market – By End User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
South and Central America Embolization Agents Market– By Country
- Brazil
- Argentina
- Rest of South and Central America
South and Central America Embolization Agents Market-Companies Mentioned
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
South and Central America Embolization Agents Report Scope
Report Attribute
Details
Market size in 2021
US$ 167.17 Million
Market Size by 2028
US$ 262.40 Million
Global CAGR (2021 - 2028)
6.7%
Historical Data
2019-2020
Forecast period
2022-2028
Segments Covered
By Product - Coils
- Plugs
- Beads/ Particles
- Detachable Balloons
- Glue
- Sponge
- Liquid Embolics
- Sclerosants
- Precipitating Agents
By Application - Oncology
- Neurology
- Urology
- Cardiology
- Peripheral Vascular Diseases
By End User - Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
Regions and Countries Covered
South and Central America - Brazil
- Argentina
- Rest of South and Central America
Market leaders and key company profiles
Abbott
Boston Scientific Corporation
Cook Medical LLC
DePuy Synthes
KANEKA CORPORATION
Medtronic
Merit Medical Systems Inc
Stryker Corporation
Terumo Corporation
South and Central America Embolization Agents Market – By End User
- Hospitals
- Cardiac Centers
- Ambulatory Surgical Centers
- Others
South and Central America Embolization Agents Market– By Country
- Brazil
- Argentina
- Rest of South and Central America
South and Central America Embolization Agents Market-Companies Mentioned
- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation
South and Central America Embolization Agents Report Scope
Report Attribute | Details |
---|---|
Market size in 2021 | US$ 167.17 Million |
Market Size by 2028 | US$ 262.40 Million |
Global CAGR (2021 - 2028) | 6.7% |
Historical Data | 2019-2020 |
Forecast period | 2022-2028 |
Segments Covered |
By Product
|
Regions and Countries Covered | South and Central America
|
Market leaders and key company profiles |
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.















- Abbott
- Boston Scientific Corporation
- Cook Medical LLC
- DePuy Synthes
- KANEKA CORPORATION
- Medtronic
- Merit Medical Systems Inc
- Stryker Corporation
- Terumo Corporation


